Literature DB >> 21082296

Response to the case report by Mattar: Generic Imatinib (Imatib, Cipla) in a patient with chronic myeloid leukemia in chronic phase.

Jaideep Gogtay, Siddharth Chahchad, Sonali Jadhav, Shrinivas Purandare.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21082296     DOI： 10.1007/s12185-010-0718-2

Source DB:  PubMed          Journal:  Int J Hematol        ISSN： 0925-5710            Impact factor:   2.490


× No keyword cloud information.
  1 in total

1.  Failure of copy Imatib (CIPLA, India) to maintain hematologic and cytogenetic responses in chronic myeloid leukemia in chronic phase.

Authors:  Mervat Mattar
Journal:  Int J Hematol       Date:  2010-01       Impact factor: 2.490
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.